October 11th, 2026Using Complement Inhibitors in GA Comes With Pros and ConsPanelists engaged in a debate regarding using complement inhibitors in geographic atrophy, gauging public sentiment with a deciding vote.Read more
October 11th, 2026Big Data, MIGS Are Crucial Areas of Glaucoma Treatment: AAO PanelA session at AAO 2026 highlighted how big data and minimally invasive glaucoma surgery (MIGS) could be utilized to help patients receive peak care.Read more
October 10th, 2026Keynote Address Tackles AI’s Role in Health Care, Eye CareThe opening session of AAO 2026 featured a keynote speech discussing how artificial intelligence (AI) will play a part in health care.Read more
October 10th, 2026GLP-1s Have Protective Benefit Against DME, Glaucoma SurgeryIncidence of diabetic macular edema and the need for glaucoma surgery were reduced after treatment with glucagon-like peptide-1 receptor agonists. Read more
October 10th, 2026Medicaid Expansion Associated With Lower Colorectal Cancer MortalityMedicaid expansion was associated with lower colorectal cancer mortality, with the largest reductions in Hispanic patients and stage IV disease.Read more
October 8th, 2026FDA Approves IV, Subcutaneous Atezolizumab for dMMR Colon CancerThe FDA approves atezolizumab with a fluoropyrimidine and oxaliplatin as adjuvant therapy for stage III dMMR colon cancer based on the ATOMIC trial.Read more
October 8th, 2026AI, Eye Care Will Take Center Stage at AAO 2026The conference, held in New Orleans, Louisiana, by the American Academy of Ophthalmology, will offer 3 full days of content spanning from glaucoma to dry eye.Read more
October 7th, 2026As Mantle Cell Lymphoma Risk Tools Advance, Access Lags BehindBiomarker-driven care is advancing in mantle cell lymphoma, though cost and infrastructure limit access in community oncology, according to a review.Read more